
Purchase SGT-263/151/25/67/78
With us securely! - re-shipment guarantees.
We always offer new legal products of impeccable quality.
Please make sure that the product is legal in your country and not under control before ordering.
We do not sell pharmaceutical products or controlled products.
Where to buy SGT-263/151/25/67/78 for sale
CUMYL-4CN-BINACA is an indazole-3-carboxamide-based synthetic cannabinoid sold online as a designer drug. It is a potent agonist for cannabinoid receptors CB1 and CB2, with in vitro EC50 values of 0.58 nM and 6.12 nM, respectively. CUMYL-5F-P7AICA is a pyrrolo[2,3-b] pyridine-3-carboxamide-based synthetic cannabinoid sold as a designer drug. The EMCDDA first identified it in February 2015.
CUMYL-4CN-BINACA (also known as CUMYL-CYBINACA or SGT-78) is an indazole-3-carboxamide-based synthetic cannabinoid sold online as a designer drug. It is a potent agonist for cannabinoid receptors CB1 and CB2, with in vitro EC50 values of 0.58 nM and 6.12 nM, respectively.
CUMYL-4CN-BINACA (also known as CUMYL-CYBINACA or SGT-78), 5F-CUMYL-P7AICA (also known as CUMYL-5F-P7AICA or SGT-263), and CUMYL-PEGACLONE (SGT-151) are synthetic cannabinoids. They possess multiple pharmacological effects, including analgesic effects, cardiovascular effects and mood stimulation.
These are synthetic cannabinoids. They possess multiple pharmacological effects, including analgesic effects, cardiovascular effects, and mood stimulation.
5F-CUMYL-P7AICA is a synthetic cannabinoid that has been sold as a designer drug. It was initially sold in China and Japan, though it has since spread to other countries. In the United States, 5F-CUMYL-P7AICA has been linked to at least one death, and several hospitalizations in Arizona (with symptoms of agitation, confusion and seizures) have been linked to an overdose of the drug.
5F-CUMYL-P7AICA is a synthetic cannabinoid that has been sold as a designer drug. It was initially sold in China and Japan, though it has since spread to other countries. 5F-CUMYL-P7AICA has been linked to at least one death in the United States, several hospitalizations with symptoms of agitation and confusion in Arizona, and seizures.
5F-CUMYL-P7AICA is a synthetic cannabinoid closely related to UR-144, XLR-11 and AB-FUBINACA.
5F-CUMYL-P7AICA is a designer drug.
CUMYL-4CN-BINACA (also known as CUMYL-CYBINACA or SGT-78) is an indazole-3-carboxamide-based synthetic cannabinoid sold online as a designer drug. It is a potent agonist for cannabinoid receptors CB1 and CB2, with in vitro EC50 values of 0.58 nM and 6.12 nM, respectively.
CUMYL-4CN-BINACA (also known as CUMYL-CYBINACA or SGT-78) is an indazole-3-carboxamide-based synthetic cannabinoid sold online as a designer drug. It is a potent agonist for cannabinoid receptors CB1 and CB2,
CUMYL-4CN-BINACA and 5F-CUMYL-P7AICA have been identified as cannabinoids of emerging concern. CUMYL-4CN-BINACA was first identified in June 2015 by the EMCDDA and has been sold online as a designer drug.
Commonly used as a research chemical and has been linked to deaths. The compound is also identified with other names, including SGT-263, 5F-CUMYL-P7AICA, CUMYL-5F-P7AICA and respectively as SGT-25, SGT-67, CUMYL-4CN-BINACA(CUMYL-CYBINACA).
CUMYL-4CN-BINACA is an indazole-3-carboxamide-based synthetic cannabinoid sold online as a designer drug. SGT-263/151/25/67/78 are pyrrolo[2,3-b]pyridine-3-carboxamide based synthetic cannabinoids that have been sold as designer drugs
CUMYL-4CN-BINACA (also known as CUMYL-CYBINACA or SGT-78) is an indazole-3-carboxamide-based designer synthetic cannabinoid with potent agonist activity for CB1 and CB2.
To prepare the content, the following materials were used:
- FDA Substance Registration System
- Hazardous Substances Data Bank. National Library of Medicine. 28 August 2008. Retrieved 22 August 2014. 3,4-Methylenedioxymethamphetamine
- Liver transplant modulates gut microbial dysbiosis and cognitive function in cirrhosis. PDF . By HoChong Gilles, Scott C Matherly, Mohammed S Siddiqui, Puneet Puri...
- Differential impact of hyponatremia and hepatic encephalopathy on health-related quality of life and brain metabolite abnormalities in cirrhosis . By Jasmohan Bajaj
- An overview of alcohol and other drug issues
- Medicating the mind: a Kantian analysis of overprescribing psychoactive drugs B A Manninen
- The pharmacological basis of opioids Carla Ghelardini, Lorenzo Di Cesare Mannelli and Enrica Bianchi
- Ask Dr. Shulgin Online ARCHIVE: June 3, 2004
- Inhibition of plasma membrane monoamine transporters by β-ketoamphetamines. Nicholas V Cozzi, Michael KSievert, Alexander T Shulgin, Peyton JacobIII, Arnold Eruoho
- Schedules of Controlled Substances: Placement of Methylone Into Schedule I
- Bioanalysis of new designer drugs. Wohlfarth A, Weinmann W.
- New Psychoactive Substances (including synthetic cannabinoids, mephedrone, and more)
- Future Synthetic Drugs of Abuse. Donald A. Cooper. Drug Enforcement Administration McLean, Virginia
- Designer drugs: a medicinal chemistry perspective. F. Ivy Carroll Anita H. Lewin S. Wayne Mascarella Herbert H. Seltzman P. Anantha Reddy
- Synthetic cannabinoids in Europe
- Pharmacological Effects of MDMA in Man. By Enno Freye
- Drug Use in Relation to Outcome of Mammography Screening. von Euler-Chelpin M, Wu W, Vejborg and Lynge E
- DEA Drug Scheduling
- Electrophysiological Effects of Trace Amines on Mesencephalic Dopaminergic Neurons.Ada Ledonne, Nicola Berretta, Alessandro Davoli, Giada Ricciardo Rizzo, Giorgio Bernardi and Nicola Biagio Mercuri
- Electrophysiological evidence for a reciprocal interaction between amphetamine and cocaine-related drugs on rat midbrain dopaminergic neurons.Scarponi M, Bernardi G, Mercuri NB.
- Overdose of Drugs for Attention-Deficit Hyperactivity Disorder: Clinical Presentation, Mechanisms of Toxicity, and Management. Henry A. Spiller, author Hannah L. Hays Alfred Aleguas.
- Dose-dependent effectiveness of wheel running to attenuate cocaine-seeking: impact of sex and estrous cycle in rats. Peterson AB, Hivick DP, Lynch WJ.r.
- FDA Drug Safety Communication: Safety Review Update of Medications used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in children and young adults
- ADHD Medications and Risk of Serious Cardiovascular Events in Young and Middle-aged Adults
- Controlled Substances Act
- The Art of Drug Synthesis (Wiley Series on Drug Synthesis)
- Cannabis: domestic cultivation widespread
- A review of the influence of functional group modifications to the core scaffold of synthetic cathinones on drug pharmacokinetics
1kg $1890
100g $390
1kg $1590
500g $1700
100g $490
1kg $1690
500g $1199
1kg $2100
1000 pills $45
100g $390
300g $840